Drug Discovery and Development Consultants was founded in 2018 with the objective of addressing a need in the market through offering a consultancy service providing support and advice across all aspects of drug discovery and development. As a team we benefit from the advantage of having worked together for many years thus providing obvious efficiencies in ensuring cost effective and timely delivery of our client’s objectives. We also benefit from access to an extended network of both industry and academia-based associates as befits our longevity in the industry. Our collective experience includes examples of: Discovery and implementation of new technologies Drug target identification Drug discovery activities through hit ID, LG, LO and drug candidate nomination Non-clinical development campaigns including pharmacology, drug metabolism and pharmacokinetics (DMPK), drug candidate scale-up, CMC, exploratory and GLP tox Programme leadership/management/budget preparation/project planning Executing programmes as a virtual team from discovery to Phase 1 first time in human and Phase 2 POC Clinical Operations expertise in Phase 1 clinical studies including First in Human and Phase 2 POC Establishing and maintaining a Quality Management System for Biotech Companies Regulatory and QA advice In-licensing and out-licensing activities including due diligence activities Working in partnerships with big pharma, biotechs and CROs Company start-ups and sales